Robin Phillips
Gynecology · New York, NYNPI 1306938378
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,265 and has fallen 86.5% since, to $171 in 2025.
Across 89 payments — averaging $25.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$366
- Lilly USA, LLC$350
- Vertical Pharmaceuticals, LLC$280
- Astellas Pharma US Inc$231
- Therapeuticsmd, Inc.$228
- Aspira Women's Health Inc$119
- plus $696 from 14 others
What the payments were for
- Food & beverage$2,18196%
- Education$733%
- Gifts$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $366 |
| Lilly USA, LLC | 7 | $350 |
| Vertical Pharmaceuticals, LLC | 9 | $280 |
| Astellas Pharma US Inc | 6 | $231 |
| Therapeuticsmd, Inc. | 7 | $228 |
| Aspira Women's Health Inc | 1 | $119 |
| Millicent US Inc | 7 | $115 |
| Amgen | 5 | $111 |
| AMAG Pharmaceuticals, Inc. | 3 | $59 |
| Ascend Therapeutics US, LLC | 3 | $58 |
| Amarin Pharma, Inc. | 3 | $57 |
| Aytu Biopharma, Inc. | 3 | $50 |
| Corcept Therapeutics | 3 | $49 |
| Pfizer | 3 | $47 |
| Exeltis, USA Inc. | 2 | $42 |
| Antares Pharma, Inc. | 2 | $35 |
| IBSA Pharma Inc. | 1 | $21 |
| Acerus Pharmaceuticals Corporation | 1 | $18 |
| Mannkind Corporation | 1 | $18 |
| Avion Pharmaceuticals | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,270 in reported general payments places this provider in the 80th percentile of 240 gynecology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProliaDenosumab | 19 | $32,373 |
| EstringEstradiol | 32 | $16,810 |
| Estradiol | 77 | $10,346 |
| DivigelEstradiol | 11 | $4,323 |
| YuvafemEstradiol | 19 | $2,965 |
| Ibandronate Sodium | 39 | $1,744 |
| Estradiol (Twice Weekly)Estradiol | 13 | $1,048 |
| Raloxifene Hcl | 22 | $1,007 |
| ProgesteroneProgesterone, Micronized | 28 | $847 |
| ValacyclovirValacyclovir Hcl | 24 | $375 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProlia | $111 | $32,37319 claims |
| PfizerEstring | $47 | $16,81032 claims |
| Vertical Pharmaceuticals, LLCDivigel | $280 | $4,32311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 240 gynecology providers in New York.
Other gynecology in New York
- Arnold AdvinculaNew York$2.1M
- Tamara KolevNew York$91K
- Charles Ascher-WalshNew York$43K
- Paula CastanoNew York$31K
- Christopher EswarNew York$25K
- Neena AgarwalaNew York$17K
- Tara AllmenNew York$8K
- Jorge VenegasNew York$7K
- Molly McBrideNew York$7K
- Connie LiuNew York$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.